IRBS Financials 07/15/2014 20:43:55 IR Bioscience
Post# of 3
Posted On: 07/15/2014 9:43:52 PM
IRBS Financials 07/15/2014 20:43:55
IR Biosciences Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development -
Sales, General and Admin. 2,860
Non-Recurring Items -
Other -
Operating Income (2,860)
Income From Continuing Operations
Add'l Income/Expense Items (716)
Earnings Before Interest and Tax (5,282)
Interest Expense -
Earnings Before Tax (5,282)
Income Tax (4)
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (10,710)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (5,278)
Preferred Stock and Other Adjustments (129)
Net Income Applicable to Common Shareholders (5,407)
IR Biosciences Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development -
Sales, General and Admin. 2,860
Non-Recurring Items -
Other -
Operating Income (2,860)
Income From Continuing Operations
Add'l Income/Expense Items (716)
Earnings Before Interest and Tax (5,282)
Interest Expense -
Earnings Before Tax (5,282)
Income Tax (4)
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (10,710)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (5,278)
Preferred Stock and Other Adjustments (129)
Net Income Applicable to Common Shareholders (5,407)
(0)
(0)Ir Biosciences Hldgs (IRBS) Stock Research Links
Scroll down for more posts ▼